跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA COMBIX 5 MG CÁPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA COMBIX 5 MG CÁPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA COMBIX 5 MG CÁPSULAS DURAS EFG
Laboratorios Combix S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 10, 2023
Approval ID
cd5f56a49a996872
Company
Laboratorios Combix S.L.U.
Type
Standard
Approval Details
Approval Id
cd5f56a49a996872
Drug Cima Aemps Name
LENALIDOMIDA COMBIX 5 MG CÁPSULAS DURAS EFG
Register Number
88952
Holder Company Name
Laboratorios Combix S.L.U.
Marketing Company Name
Laboratorios Combix S.L.U.
Authorization Date
2023-07-10
Dosage Form
CÁPSULA DURA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Laboratorios Combix S.L.U.
Active Ingredients
LENALIDOMIDA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 10, 2023
Approval ID
cd5f56a49a996872
Type
Standard
Back to CIMA-AEMPS Approvals
